HOME >> BIOLOGY >> NEWS
Million dollar grant by the Paul G. Allen Foundation for Medical Research to University of Washington medical scientist program

"We are pleased to support the University of Washington School of Medicine in exploring new healthcare frontiers. We anticipate a fruitful relationship that will benefit the entire Pacific Northwest region," said Jody Patton, executive director of the foundation. The MST program, established in 1970, was designed to produce talented, creative and dedicated physician scientists capable of translating new advances in biotechnology, informatics and genetics into patient-care enhancements. The program is fulfilling its mission with many graduates involved in dynamic research projects. These projects are leading to the development of new medications and new strategies for immunotherapy, as well as the identification of hereditary factors related to leukemia.

"This grant opens further opportunities for doctors to enhance their skills as scientists," said Dr. Lawrence Loeb, the director of the MST program. "It enhances our mission of training these exceptional students so they emerge with the knowledge, experience, and self-confidence to create breakthroughs in medical research."

Loeb added his thanks to Dr. Mary-Claire King, a professor at University of Washington School of Medicine, who first approached the foundation with the suggestion it support the MST program. Students in the MST program complete an 8-year combined M.D./Ph.D. degree program. MST scholars are selected for their history of academic excellence and their potential as future physician scientists. Admission is highly competitive.

Seven Allen Scholars have been named as the first beneficiaries of the grant that will pay the program $250,000 a year over 4 years. Four fellows began their tenure Dec. 1, 2000. The other three start July 1, 2001. The 7 will work on research projects reflecting a variety of interests, including genetics, disease pathogenesis, cellular and molecular biology and rehabilitation medicine.

Kyle Garton, of Lincoln, Nebraska, graduated wi
'"/>

Contact: Pam Sowers
sowerspl@u.washington.edu
206-685-4232
University of Washington
5-Feb-2001


Page: 1 2 3

Related biology news :

1. $7.5 Million grant to Yale researchers for role of viruses in cancer
2. K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense
3. 5 Million award for pioneering project to train new breed of scientists
4. 2 Million of yeast to triple available drug treatments
5. $10 Million center for theoretical biological physics created at UCSD by NSF
6. $14 Million NIH grant launches heart, lung, blood and sleep disorders center at the Jackson Laboratory
7. NSF awards $4.2 Million grants to three coastal sites for long-term ecological research
8. JDF awards $10 Million to Childrens Hospital of Pittsburgh and University of Pittsburgh for new research center to help speed diabetes cure
9. AVAX Technologies receives an additional $3.0 Million (AUD) investment in Australian joint venture from Australian Vaccine Technologies Ltd.
10. Columbia University College of Physicians and Surgeons receives $2.4 Million grant from Howard Hughes Medical Institute
11. UCSF School of Medicine receives $3.8 Million grant for biomedical research

Post Your Comments:
(Date:5/23/2013)... Inside the natural history museums of the world are ... and beetles to flowers, mushrooms and grasses, all stacked, ... The rich and diverse collections could be critical to ... face of a growing human footprint if only ... project, brought to life with the help of a ...
(Date:5/22/2013)... investigators also conclude that the 20 percent reduction ... (LDCT) versus chest X-ray (CXR) screening previously reported ... experienced screening centers in the United States. , ... their patients about the benefits and risks of ... the New England Journal of Medicine ...
(Date:5/22/2013)... engineering drastically reduces the time and effort needed ... of biotechnology, scientists are reporting. Published in the ... paves the way for more rapid development of ... other activities. , Keith Shearwin and colleagues explain ... genetic material DNA into a bacterium,s genome is ...
Breaking Biology News(10 mins):CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3
(Date:5/23/2013)... May 23, 2013 Virobay, Inc. today announced ... has reached an important milestone, as Virobay has now ... a selective cathepsin S inhibitor.   The ... randomized, placebo-controlled study designed to evaluate the safety, tolerability, ... healthy adults. "The initiation of this Phase ...
(Date:5/23/2013)... On April 19th the Center for Disease ... the growing antibiotic resistant bacteria that may be lurking ... study were released late last month showing higher antibiotic ... years. For those suffering from bacteria driven acne, Probiotic ... in food, may eventually help breed acne causing bacteria. ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
(Date:5/23/2013)... EASTON, Mass. , May 23, 2013 ... today announced that the Company will host a teleconference ... to provide a business update. The teleconference information is ... Time: 11:00 a.m. Eastern Daylight Time (EDT) ... ); (302) 607-2001 (Int,l) Passcode: VS22823 ...
Breaking Biology Technology:Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2
Cached News: